Bio-Rad Laboratories (BIO) EBT Margin (2009 - 2026)
Bio-Rad Laboratories (BIO) reported EBT Margin of 116.5% for Q1 2026, down 13075.0% year-over-year from N/an in Q1 2025, and down 186.91% on a QoQ basis from 134.05% in Q4 2025.
Bio-Rad Laboratories (BIO) has 18 years of EBT Margin data on file, last reported at 116.5% in Q1 2026.
- Quarterly EBT Margin fell 13075.0% year-over-year to 116.5% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 8.58% (up 11681.0% YoY) and the FY2025 annual result came in at 38.54%, up 12981.0% from the prior year.
- EBT Margin eased to 116.5% in Q1 2026 per BIO's latest filing, from 134.05% in the prior quarter.
- Across five years, EBT Margin topped out at 149.45% in Q4 2022 and bottomed at 623.91% in Q1 2022.
- The 5-year median for EBT Margin is 12.53% (2023), against an average of 66.76%.
- The widest annual swing landed in 2022, when EBT Margin plunged 80239 bps; it then jumped 63644 bps in 2023.
- Tracing BIO's EBT Margin over 5 years: stood at 149.45% in 2022, then tumbled by 58 bps to 62.89% in 2023, then tumbled by 317 bps to 136.16% in 2024, then surged by 198 bps to 134.05% in 2025, then slumped by 187 bps to 116.5% in 2026.
- Per Business Quant, the three latest BIO EBT Margin figures stand at 116.5% (Q1 2026), 134.05% (Q4 2025), and 66.02% (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 12.98% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 14.12% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 15.57% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 22.33% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 27.84% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 4.87% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 22.61% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | 9.84% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 19.17% |
| 10 | Bio-Rad Laboratories | 8.23 Bn | 6.66 Bn | 309.40 Mn | -116.50% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -116.50% |
| Dec 31, 2025 | 134.05% |
| Sep 30, 2025 | -66.02% |
| Jun 30, 2025 | 63.54% |
| Mar 31, 2025 | 14.25% |
| Dec 31, 2024 | -136.16% |
| Sep 30, 2024 | 132.62% |
| Jun 30, 2024 | -436.38% |
| Mar 31, 2024 | 80.40% |
| Dec 31, 2023 | 62.89% |
| Sep 30, 2023 | 21.69% |
| Jun 30, 2023 | -220.29% |
| Mar 31, 2023 | 12.53% |
| Dec 31, 2022 | 149.45% |
| Sep 30, 2022 | -30.45% |
| Jun 30, 2022 | -176.56% |
| Mar 31, 2022 | -623.91% |
| Dec 31, 2021 | -276.63% |
| Sep 30, 2021 | 672.32% |
| Jun 30, 2021 | 161.59% |
| Mar 31, 2021 | 178.48% |
| Dec 31, 2020 | 137.87% |
| Sep 30, 2020 | 260.23% |
| Jun 30, 2020 | 232.06% |
| Mar 31, 2020 | 157.23% |
| Dec 31, 2019 | 111.99% |
| Sep 30, 2019 | -59.80% |
| Jun 30, 2019 | 134.40% |
| Mar 31, 2019 | 203.48% |
| Dec 31, 2018 | -168.78% |
| Sep 30, 2018 | 64.23% |
| Jun 30, 2018 | 59.05% |
| Mar 31, 2018 | 156.61% |
| Dec 31, 2017 | 7.39% |
| Sep 30, 2017 | 5.73% |
| Jun 30, 2017 | 0.22% |
| Mar 31, 2017 | 4.02% |
| Dec 31, 2016 | -4.92% |
| Sep 30, 2016 | 4.46% |
| Jun 30, 2016 | 5.21% |
| Mar 31, 2016 | 4.29% |
| Dec 31, 2015 | 9.50% |
| Sep 30, 2015 | 5.41% |
| Jun 30, 2015 | 7.81% |
| Mar 31, 2015 | 5.65% |
| Dec 31, 2014 | 7.65% |
| Sep 30, 2014 | 4.24% |
| Jun 30, 2014 | 9.09% |
| Mar 31, 2014 | 2.85% |
| Dec 31, 2013 | 7.39% |
| Sep 30, 2013 | -1.03% |
| Jun 30, 2013 | 9.34% |
| Mar 31, 2013 | 4.81% |
| Sep 30, 2012 | 11.03% |
| Jun 30, 2012 | 12.93% |
| Mar 31, 2012 | 9.50% |
| Dec 31, 2011 | 15.27% |
| Sep 30, 2011 | 10.80% |
| Jun 30, 2011 | 11.08% |
| Mar 31, 2011 | 9.95% |
| Dec 31, 2010 | 10.72% |
| Sep 30, 2010 | 12.28% |
| Jun 30, 2010 | 11.84% |
| Mar 31, 2010 | 10.97% |
| Dec 31, 2009 | 8.50% |
| Sep 30, 2009 | 11.11% |
| Jun 30, 2009 | 11.53% |